Hypercholesterolemia is a strong determinant of mortality and morbidity associated with cardiovascular diseases and a major contributor to the global disease burden. Mutations in …
Large-scale meta-analyses of genome-wide association studies (GWAS) have identified> 175 loci associated with fasting cholesterol levels, including total cholesterol (TC), high …
Implementing precision medicine for complex diseases such as chronic obstructive lung disease (COPD) will require extensive use of biomarkers and an in-depth understanding of …
Y Zhu, D Zhang, D Zhou, Z Li, Z Li… - Journal of cellular …, 2017 - Wiley Online Library
Metabolic syndrome (MetS), a cluster of metabolic disturbances that increase the risk for cardiovascular disease and diabetes, was because of genetic susceptibility and …
R Wuni, GGC Kuhnle, AA Wynn-Jones… - Current Atherosclerosis …, 2022 - Springer
Abstract Purpose of Review An abnormal lipid profile is considered a main risk factor for cardiovascular diseases and evidence suggests that single nucleotide polymorphisms …
X Lu, J Huang, Z Mo, J He, L Wang… - Circulation …, 2016 - Am Heart Assoc
Background—Multiple genetic loci associated with lipid levels have been identified predominantly in Europeans, and the issue of to what extent these genetic loci can predict …
M Mamtani, H Kulkarni, TD Dyer, HHH Göring… - Clinical …, 2016 - Springer
Background There is growing interest in the hypertriglyceridemic waist (HTGW) phenotype, defined as high waist circumference (≥ 95 cm in males and≥ 80 cm in females) combined …
R Cacabelos, C Torrellas, O Teijido… - Pharmacogenomics, 2016 - Taylor & Francis
The practical pharmacogenetics of Alzheimer's disease (AD) is circumscribed to acetylcholinesterase inhibitors (AChEIs) and memantine. However, pharmacogenetic …
Inbred mice exhibit strain-specific variation in susceptibility to atherosclerosis and dyslipidemia that renders them useful in dissecting the genetic architecture of these complex …